prod:prod_dcx-login
Xpert® MRSA/SA SSTI
Detect MRSA & SA skin and soft tissue infection in about one hour
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
GXMRSA/SA-SSTI-CE
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
Collection Device (Pack of 50)
900-0370
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
- Surgical-site infections (SSIs) are a significant cause of morbidity and mortality1
- S. aureus is one of the most common pathogens responsible for SSIs2
- SSIs caused by MRSA lead to worse clinical outcomes vs less resistant pathogens2
- The use of inappropriate initial antibiotic treatment can be associated with adverse clinical outcomes and increased length of stay3
1 Mengistu DA, Alemu A, Abdukadir AA, Mohammed Husen A, Ahmed F, Mohammed B, Musa I. Global Incidence of Surgical Site Infection Among Patients: Systematic Review and Meta-Analysis. Inquiry. 2023 Jan-Dec;60:469580231162549. doi: 10.1177/00469580231162549. PMID: 36964747; PMCID: PMC10041599.
2 Seidelman JL, Mantyh CR, Anderson DJ. Surgical Site Infection Prevention: A Review. JAMA. 2023;329(3):244–252. doi:10.1001/jama.2022.24075
3 Nathwani D, et al. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents. 2016
2 Seidelman JL, Mantyh CR, Anderson DJ. Surgical Site Infection Prevention: A Review. JAMA. 2023;329(3):244–252. doi:10.1001/jama.2022.24075
3 Nathwani D, et al. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents. 2016
The Solution
The Xpert MRSA/SA SSTI test is a qualitative in vitro diagnostic test intended for the detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) from skin and soft tissue infection swabs
- Laboratory efficiencies with on-demand workflows requiring minimal hands-on time
- Optimized therapy to support improved patient outcomes and reduced empirical prescribing
The Impact
- Rapid detection enables more targeted antibiotic selection4
- Improved patient management with appropriate antimicrobial therapy5
- Significantly reduced time to result compared to culture methods5
4 May LS, et al. A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care. Infect Control Hosp Epidemiol. 2015
5 Valour et al. (2014) Rapid detection of Staphylococcus aureus and methicillin resistance in bone and joint infection samples: evaluation of the GeneXpert MRSA/SA SSTI assay https://www.sciencedirect.com/science/article/pii/S0732889313006391
5 Valour et al. (2014) Rapid detection of Staphylococcus aureus and methicillin resistance in bone and joint infection samples: evaluation of the GeneXpert MRSA/SA SSTI assay https://www.sciencedirect.com/science/article/pii/S0732889313006391
Related Products
Xpert Carba-R
Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 50 minutes
Xpert SA Nasal Complete
Pre-surgical S. aureus and MRSA in about 65 minutes
Xpert C. difficile BT
Detection of Clostridium difficile infection with an independent call-out of binary toxin and differentiation of the 027 strain in around 45 minutes
Xpert Norovirus
Fast and accurate identification of Norovirus GI & GII in as little as one hour* *With early assay termination for positive results. Reporting negative results in 90 minutes.
Xpert MRSA NxG
Active MRSA surveillance testing in around 70 minutes
Xpert MRSA/SA Blood Culture
Accurate Detection of MRSA and SA in Positive Blood Culture Specimens in About an Hour
Xpert vanA/vanB
Rapid VRE screening for active outbreak prevention and control in around 48 minutes